Fund Description

Technology is transforming healthcare. Not only are genomic treatments for several diseases becoming more affordable, but also digitalized healthcare is growing fast. VanEck’s Genomics and Healthcare Innovators UCITS ETF invests in the businesses pioneering ways to treat disease and connect with patients.The Fund has a sustainable investment objective, with an emphasis on social objectives:

• Invest in genomics companies developing new ways to treat health problems such as genetic conditions, cancer and conditions related to ageing
• Gain exposure to digital health services providers – delivering easy access to doctors, physiotherapists, nurses and pharmacists
• Pure-play exposure to companies earning at least half their revenues from genomics- or e-healthcare-related industries
• Invest in an ETF that screens out companies that violate social norms, derive revenues from controversial weapons, or participate in fossil fuel sectors, nuclear power, civilian firearms or tobacco

Main Risk Factors: Equity market risk, industry concentration risk, Liquidity Risks. Investors must consider all the fund's characteristics or objectives as detailed in the prospectus or related documents before making an investment decision. Please refer to the sustainability-related disclosures in the document section, to the

and the Prospectus for other important information before investing.